| 000 | 01710 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513134513.0 | ||
| 264 | 0 | _c19980414 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0022-3077 | ||
| 024 | 7 |
_a10.1152/jn.1998.79.2.555 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVicini, S | |
| 245 | 0 | 0 |
_aFunctional and pharmacological differences between recombinant N-methyl-D-aspartate receptors. _h[electronic resource] |
| 260 |
_bJournal of neurophysiology _cFeb 1998 |
||
| 300 |
_a555-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCysteic Acid _xpharmacology |
| 650 | 0 | 4 |
_aDNA, Complementary _xgenetics |
| 650 | 0 | 4 | _aFluorescent Antibody Technique, Indirect |
| 650 | 0 | 4 | _aGenes, Reporter |
| 650 | 0 | 4 |
_aGlutamic Acid _xpharmacology |
| 650 | 0 | 4 |
_aHaloperidol _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKidney |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 | _aProtein Multimerization |
| 650 | 0 | 4 | _aRNA Splicing |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xchemistry |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xchemistry |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aWang, J F | |
| 700 | 1 | _aLi, J H | |
| 700 | 1 | _aZhu, W J | |
| 700 | 1 | _aWang, Y H | |
| 700 | 1 | _aLuo, J H | |
| 700 | 1 | _aWolfe, B B | |
| 700 | 1 | _aGrayson, D R | |
| 773 | 0 |
_tJournal of neurophysiology _gvol. 79 _gno. 2 _gp. 555-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1152/jn.1998.79.2.555 _zAvailable from publisher's website |
| 999 |
_c9432393 _d9432393 |
||